Abstract:OBJECTIVE:To investigate the clinical characteristics and predictors of mortality in patients with candidemia in intensive care unit (ICU).METHODS:The patients with candidemia admitted to ICU of Peking University People's Hospital from January 2010 to December 2017 were enrolled. The general clinical data, indicators related to Candidia infection and prognosis were collected, and the clinical characteristics, infection characteristics and prognosis of patients with candidiasis were analyzed. Patients were divided into death group and survival group according to hospital survival status. The differences of each index were compared between two groups. The independent risk factors of mortality in patients with candidemia were analyzed by multivariate Logistic regression analysis.RESULTS:A total of 95 patients (55 males) with candidemia were included, with an average age of (69.3±16.5) years, acute physiology and chronic health evaluation II (APACHE II) was 24.7±3.6, sequential organ failure assessment (SOFA) was 6.6±2.7. Candida albicans accounted for the largest proportion of Candida infections (n = 56, 58.9%). Thirty-two (33.7%) patients received inadequate antifungal therapy and 38 (40.0%) patients received inadequate source control. Fifty-five (57.9%) patients were died in hospital. Compared with the survival group, patients in the death group was older (years: 72.5±14.6 vs. 64.9±18.0, P < 0.05), had higher APACHE II and SOFA scores (26.6±2.2 vs. 22.1±3.6, 7.9±2.0 vs. 4.7±2.4, both P < 0.01), higher rate of glucocorticoid treatment (18.2% vs. 10.0%, P < 0.05), and higher proportion of Candida albicans and Candida glabrata (69.1% vs. 45.0%, 10.9% vs. 7.5%, both P < 0.05), the rate of multi-site Candida infection also significantly increased (47.3% vs. 17.5%, P < 0.05). Intra-abdominal infection was the primary infection site and more common in death group (49.1% vs. 35.0%, P < 0.05). The rates of sepsis (87.3% vs. 62.5%), inadequate antifungal therapy (49.1% vs. 10.0%), inadequate source control (60.0% vs. 12.5%) in death group were all higher than those in survival group (all P < 0.01). It was shown by multivariate Logistic regression analysis that APACHE II [odds ratio (OR) = 1.605, P = 0.002, β = 0.473], SOFA (OR = 1.501, P = 0.029, β = 0.406), inadequate antifungal therapy (OR = 12.084, P = 0.006, β = 2.492) and inadequate source control (OR = 7.332, P = 0.024, β = 1.992) were independent risk factors for mortality in ICU patients with candidemia.CONCLUSIONS:Candidemia patients were severe and had poor prognosis. APACHE II, SOFA, inadequate antifungal therapy and inadequate source control were independent risk factors of mortality.

Role of source control in critically ill candidemic patients: a multicenter retrospective study

Clinical analysis of 14 cases of candidemia

Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis

Epidemiology, Species Distribution, Antifungal Susceptibility and Mortality Risk Factors of Candidemia among Critically Ill Patients: a Retrospective Study from 2011 to 2017 in a Teaching Hospital in China

Clinical Features, Strain Distribution, Antifungal Resistance and Prognosis of Patients with Non-albicans Candidemia: A Retrospective Observational Study.

Clinical Features and Prognostic Risk Factors of Candidemia in Non-Intensive Care Unit Wards

Incidence, Clinical Characteristics, Risk Factors and Outcomes of Patients with Mixed Candida/bacterial Bloodstream Infections: a Retrospective Study

Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards

Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study

[Clinical Characteristics and Predictors of Mortality in Patients with Candidemia in Intensive Care Unit].

Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID‐19‐associated candidemia

Epidemiological Assessment and Risk Factors for Mortality of Bloodstream Infections by Candida sp. and the Impact of the COVID-19 Pandemic Era

Invasive Candidiasis in Intensive Care Units in China: a Multicentre Prospective Observational Study

Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients

Appropriate Source Control and Antifungal Therapy Are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis

Factors influencing outcomes in candidemia: A retrospective study of patients in a Swedish county

[Analysis of Clinical Characteristics and Risk Factors Associated with Prognosis of Patients with Candidemia].

Clinical characteristics and prognostic risk factors of candidemia in non-neutropenic patients: a retrospective cohort study

Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: A single‐centre retrospective 4‐year analysis from Hungary

Analysis of risk factors and prognosis of patients with candidemia

A 14-Year Cohort of Candidemia in the Pediatric Population in a Tertiary Center in Jerusalem: Clinical Characteristics, Antifungal Susceptibility, and Risk Factors for Mortality